Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 51.16
Day High 51.55
Open:51.44
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Free Fatty Acid Receptor 4, Pipeline Review, H2 2019 - AstraZeneca Plc & Micelle BioPharma Inc - ResearchAndMarkets.com
- BusinessWire - Mon Jan 20, 5:38AM CST
BusinessWire - CMTX
Mon Jan 20, 5:38AM CST
The "Free Fatty Acid Receptor 4 - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
'Guided-Missile' Cancer Drugs are the Biotech Sector's First Major Story of the 2020s
- PR Newswire - Wed Jan 15, 7:45AM CST
PR Newswire - CMTX
Wed Jan 15, 7:45AM CST
USA News Group - With a new decade still less than a month underway, it appears the 2020s should see some major breakthroughs in the fight against cancer. A recent analysis from Reuters uncovered that a record 89 therapies are underway in human trials that feature the pairing of treatments with antibodies with toxic agents to fight cancer--affectionately dubbed "guided-missile" cancer drugs.
Moderna Builds on Clinical Validation of Systemic Delivery with Two Additional Development Candidates in New Autoimmune Therapeutic Area
- BusinessWire - Mon Jan 13, 5:31AM CST
BusinessWire - CMTX
Mon Jan 13, 5:31AM CST
--mRNA-6981 encodes PD-L1 to treat autoimmune disease, initially to be developed in autoimmune hepatitis
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 48.85 +5.08% increase
on 12/18/19
Period Open:48.97
Price movement based on the high, low and last over the given period.
51.55 -0.43% decrease
on 01/17/20
+2.36 (+4.82%) increase
since 12/17/19
3-Month 43.65 +17.61% increase
on 10/21/19
Period Open:44.13
Price movement based on the high, low and last over the given period.
51.55 -0.43% decrease
on 01/17/20
+7.20 (+16.32%) increase
since 10/17/19
52-Week 35.30 +45.41% increase
on 01/28/19
Period Open:36.29
Price movement based on the high, low and last over the given period.
51.55 -0.43% decrease
on 01/17/20
+15.04 (+41.44%) increase
since 01/17/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies